Related Experiment Video
Updated: Feb 8, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery
Xiaodong Xie1, Yingying Zhang1, Fengqiao Li1
1Cancer Metastasis Alert and Prevention Center, and Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry; Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, Fujian 350116, China.
Background:
Effective cancer therapy is still a great challenge for modern medical research due to the complex underlying mechanisms of tumorigenesis and tumor metastasis, and the limitations commonly associated with currently used cancer therapeutic options. Nanotechnology has been implemented in cancer therapeutics with immense potential for improving cancer treatment.
Objective:
Through information about the recent advances regarding cancer hallmarks, we could comprehensively understand the pharmacological effects and explore the mechanisms of the interaction between the nanomaterials, which could provide opportunities to develop mechanism-based nanomedicine to treat human cancers.
Methods:
We collected related information and data from articles.
Results:
In this review, we discussed the characteristics of cancer including tumor angiogenesis, abnormalities in tumor blood vessels, uncontrolled cell proliferation markers, multidrug resistance, tumor metastasis, cancer cell metabolism, and tumor immune system that provide opportunities and challenges for nanomedicine to be directed to specific cancer cells and portray the progress that has been accomplished in application of nanotechnology for cancer treatment.
Conclusion:
The information presented in this review can provide useful references for further studies on developing effective nanomedicine for the treatment of cancer.
Insights
Nanotechnology offers promising solutions for cancer treatment by addressing complex hallmarks like metastasis and drug resistance. This review explores nanomaterial interactions to develop targeted nanomedicine for improved cancer therapy.
Area of Science:
- Oncology
- Materials Science
- Nanotechnology
Background:
- Cancer therapy faces challenges due to complex tumorigenesis and metastasis mechanisms.
- Current cancer treatments have limitations, driving the need for innovative approaches.
- Nanotechnology presents significant potential for enhancing cancer treatment strategies.
Purpose of the Study:
- To review recent advances in understanding cancer hallmarks.
- To explore the interaction mechanisms between nanomaterials and cancer cells.
- To identify opportunities for developing mechanism-based nanomedicine for cancer treatment.
Main Methods:
- Literature review and data collection from relevant articles.
- Comprehensive analysis of existing research on cancer hallmarks and nanomedicine.
Main Results:
- Discussed key cancer characteristics: angiogenesis, abnormal vasculature, proliferation, multidrug resistance, metastasis, metabolism, and immune evasion.
- Highlighted opportunities and challenges for nanomedicine targeting specific cancer cells.
- Detailed the progress in applying nanotechnology for cancer treatment.
Conclusions:
- The review provides valuable references for developing effective nanomedicine.
- Further research into nanomedicine is crucial for advancing cancer treatment.
- Nanotechnology holds promise for overcoming current therapeutic limitations in oncology.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Products: Biologics, Biosimilars and Interchangeables